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Introduction
Centrosomes are the major microtubule-nucleating centers in 
higher eukaryotic cells and are important in organizing mitotic 
spindle poles. Mitotic cells must establish a bipolar spindle to 
accurately segregate chromosomes and cortical cell fate deter-
minants. Central to this is the precise duplication of the cen-
trosome, a tiny organelle containing a pair of barrel-shaped 
centrioles, the duplicating elements of this organelle (Strnad 
and Gönczy, 2008). A centriole pair normally duplicates once 
per cell cycle, before mitosis, ensuring that only two centro-
somes are present to guide bipolar spindle assembly (Tsou and 
Stearns, 2006). If this process goes awry, overproduction of 
centrosomes (i.e., centrosome amplification) can lead to tran-
sient multipolar spindle formation, with consequent errors in 
chromosome segregation and aneuploidy (Ganem et al., 2009; 
Silkworth et al., 2009). Aneuploidy is a known driving force for 
tumor formation (Weaver et al., 2007), and many human tumors 
contain cells with elevated centrosome numbers and aneuploidy 
(Lingle et al., 2002; Pihan et al., 2003). Furthermore, centro-
some amplification in Drosophila melanogaster stem cells con-
fers tumor-forming potential by inducing abnormal stem cell 
division and, consequently, altering polarity and cell fate (Basto 
et al., 2008; Castellanos et al., 2008). Notably, the mechanisms 
limiting centriole duplication to one event per cell cycle are   
unclear, and the molecular alterations that promote centriole 
amplification in cancerous cells are ill defined.
Centriole duplication is governed by Plk4/Sak (Polo-like 
kinase 4/Snk-akin kinase), a conserved master regulator and 
initiator of centriole assembly (Fode et al., 1994; Bettencourt-
Dias et al., 2005; Habedanck et al., 2005). Although it is not 
clear how Plk4 initiates centriole duplication, Plk4 localizes to 
a “parent” centriole as a single asymmetric spot and modifies 
this site, making the parent competent for assembly of a pro-
centriole (or “daughter” centriole; Kleylein-Sohn et al., 2007). 
Plk4 loss of function leads to a failure in centriole duplication 
(Bettencourt-Dias et al., 2005; Habedanck et al., 2005). Con-
versely,  Plk4  overexpression  induces  centriole  amplification 
C
entriole duplication is a tightly regulated pro-
cess that must occur only once per cell cycle; 
otherwise, supernumerary centrioles can induce 
aneuploidy and tumorigenesis. Plk4 (Polo-like kinase 4) 
activity initiates centriole duplication and is regulated 
by ubiquitin-mediated proteolysis. Throughout interphase, 
Plk4 autophosphorylation triggers its degradation, thus 
preventing centriole amplification. However, Plk4 activ-
ity is required during mitosis for proper centriole du-
plication, but the mechanism stabilizing mitotic Plk4 is   
unknown. In this paper, we show that PP2A (Protein Phos-
phatase  2A
Twins)  counteracts  Plk4  autophosphorylation, 
thus stabilizing Plk4 and promoting centriole duplica-
tion. Like Plk4, the protein level of PP2A’s regulatory 
subunit, Twins (Tws), peaks during mitosis and is re-
quired for centriole duplication. However, untimely Tws 
expression stabilizes Plk4 inappropriately, inducing cen-
triole amplification. Paradoxically, expression of tumor-
promoting simian virus 40 small tumor antigen (ST), a 
reported PP2A inhibitor, promotes centrosome ampli-
fication by an unknown mechanism. We demonstrate 
that ST actually mimics Tws function in stabilizing Plk4 
and inducing centriole amplification.
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them with the competence to duplicate. During interphase, Plk4 
is recognized by SCF
Slimb ubiquitin ligase, and its consequent 
degradation is crucial in blocking centriole reduplication and 
preventing mother centrioles from assembling multiple daugh-
ters (Cunha-Ferreira et al., 2009; Rogers et al., 2009). Phosphory-
lation of the conserved Slimb-binding domain (SBD) within 
Plk4 promotes recognition by Slimb, and therefore, we set out to 
identify the kinases that prime Plk4 for degradation. Recently, 
it was reported that mammalian Plk4 autophosphorylates a re-
gion downstream of its kinase domain (KD; 50 amino acids 
containing the SBD) to promote its destruction by SCF
TrCP/Slimb 
(Guderian et al., 2010; Holland et al., 2010). Drosophila Plk4 
also contains a serine-rich region surrounding its SBD (denoted 
here  as  the  downstream  regulatory  element  [DRE];  Fig.  1,   
A and B). To test whether fly Plk4 utilizes a similar autophos-
phorylation mechanism, we generated recombinant Plk4 con-
taining the KD and DRE (Plk4-KD). We found that Plk4-KD can 
autophosphorylate in vitro and can phosphorylate kinase-dead 
Plk4-KD in trans (Fig. 1 C). As with mammalian Plk4 (Leung   
et al., 2007; Holland et al., 2010; Sillibourne et al., 2010), the 
DRE of Drosophila Plk4 is a target for autophosphorylation, as 
Plk4-KD phosphorylates purified DRE (Fig. 1 D). Furthermore, 
we found that the Plk4 kinase activity is needed for its degrada-
tion because kinase-dead Plk4 expressed in S2 cells is more sta-
ble than wild-type (wt) Plk4 (Fig. 1 E). These results support the 
hypothesis that Plk4 autophosphorylation promotes its destruc-
tion but do not exclude the possibility that other kinases also 
regulate Plk4 levels. Therefore, we performed an RNAi-based 
screen of the Drosophila kinome using S2 cells transfected with 
inducible Plk4-GFP and measured Plk4 levels by quantitative 
anti-GFP immunoblots (Table S2). As with Slimb RNAi treat-
ment, depletion of the kinase responsible for Slimb recognition 
should cause a dramatic elevation in Plk4 levels. However, no 
such kinase was identified in our screen (Fig. S2). Collectively, 
these results demonstrate that Plk4 autophosphorylation of the 
DRE is an evolutionarily conserved mechanism that regulates 
Plk4 stability and that it is unlikely that other kinases influence 
Slimb binding.
PP2A (Protein Phosphatase 2A) and  
its regulatory subunit, Twins (Tws),  
are required for centriole duplication
We next sought to determine the mechanism that stabilizes Plk4 
during mitosis. Because Slimb levels are constant throughout 
the cell cycle (Rogers et al., 2009), and Plk4 autophosphory-
lation promotes Slimb binding, we hypothesized that a serine/
threonine phosphatase might counteract this activity to stabilize 
mitotic Plk4 and promote centriole duplication. Inhibition of 
the phosphatase should promote constitutive Plk4 degradation 
and prevent centriole duplication. Notably, knockdown of PP2A 
was reported to reduce mitotic centrosome numbers in S2 cells 
(Chen et al., 2007a), suggesting that PP2A promotes centriole 
duplication. Centrioles were not directly examined in that study, 
and the findings could be explained by the inability of mitotic 
centrioles  in  PP2A-depleted  cells  to  recruit  pericentriolar 
material proteins (Dobbelaere et al., 2008). Nevertheless, PP2A 
plays numerous mitotic functions (De Wulf et al., 2009), and 
and can do so via three different pathways: (1) centriole re-
duplication (arising from the repeated separation and duplication   
of centriole pairs; Rogers et al., 2009; Dzhindzhev et al., 2010), 
(2) multiple daughter centriole assembly (manifested as a sin-
gle duplicating mother centriole assembling several daughters 
near simultaneously; Habedanck et al., 2005; Kleylein-Sohn   
et al., 2007), or (3) de novo centriole assembly (Peel et al., 2007;   
Rodrigues-Martins et al., 2007). Plk4 overexpression is onco-
genic in Drosophila, promoting multipolar spindle formation in   
neural stem cells and conveying tumor-forming potential (Basto 
et al., 2008; Castellanos et al., 2008). Intriguingly, Plk4 also 
acts as a tumor suppressor, as Plk4 heterozygotic mice display a 
high incidence of spontaneous liver tumors containing dividing 
cells with supernumerary centrosomes and multipolar spindles 
(Ko et al., 2005). However, because Plk4 also functions in cyto-
kinesis  in  mammalian  cells,  these  particular  phenotypes  are 
likely the result of cytokinesis defects (Rosario et al., 2010). 
Interestingly, expression of several viral oncoproteins can also 
induce centrosome amplification, including SV40 small tumor 
antigen (ST), human papillomavirus E7, and hepatitis B onco-
protein X (Duensing et al., 2000; Yun et al., 2004; Kotadia et al., 
2008). How these viral proteins alter the centriole duplication 
machinery is not known, but given the importance of Plk4 in 
this process and its link to cancer, it seems possible that some 
viral oncoproteins directly influence Plk4 activity.
Understanding Plk4 regulation is critical in gaining in-
sight into both the fidelity of centriole duplication and the 
etiology of centriole amplification during tumorigenesis. Plk4 
activity is primarily regulated by cell cycle control of its protein 
turnover rate (Fode et al., 1996; Rogers et al., 2009). During 
interphase, Plk4 is expressed but then maintained at low levels 
because of the activity of the SCF (Skp/Cullin/F-box) E3 ubiq-
uitin ligase complex, which recognizes phosphorylated Plk4   
via the F-box protein Slimb (-TrCP in humans; Cunha-Ferreira 
et al., 2009; Korzeniewski et al., 2009; Rogers et al., 2009). 
Slimb localizes to centrioles throughout the cell cycle and is 
properly poised to target Plk4 for proteasome-mediated deg-
radation, thus blocking Plk4 accumulation on centrioles and 
the ensuing centriole amplication that would occur (Rogers et al., 
2009). During mitosis, however, Plk4 protein levels peak, deco-
rating each centriole as a single asymmetric spot and endowing 
the centriole with the ability to duplicate (Rogers et al., 2009). 
Remarkably, Plk4 accumulates on mitotic centrioles in spite 
of centriole-associated Slimb. Although our understanding of   
Plk4 down-regulation is increasing, it is not known how Plk4 
is stabilized, nor is it clear how Plk4 regulation is altered during 
oncogenesis. In this study, we investigate the mechanism that 
stabilizes Plk4 and explore a causal link between viral oncogene 
expression, Plk4 misregulation, and centriole amplification.
Results
Drosophila Plk4 autophosphorylation 
promotes its degradation
Previously, we found that the Plk4 protein accumulates during 
mitosis in cultured Drosophila S2 cells (Fig. S1; Rogers et al., 
2009). At this time, Plk4 associates with centrioles and endows 233 PP2A stabilizes Plk4 to induce centriole amplification • Brownlee et al.
protein individually (when antibodies were available, we con-
firmed depletion by immunoblotting; Fig. S3 A) and measured 
centriole numbers in S2 cells. Depletion of Mts or PP2A-29B 
resulted in loss of centrioles (Fig. 2 A), significantly increasing 
the percentage of cells with less than two centrioles compared 
with controls (Fig. 2 B). This effect was phenocopied by treating   
cells with the PP2A inhibitor okadaic acid (OA; Fig. 2, A and B). 
Depletion of only one regulatory subunit, Tws, also significantly 
decreased centriole number (Fig. 2 B). Prolonged Tws RNAi had 
no effect on cell cycle progression (Fig. S3 B) or mitotic index 
therefore, we explored a possible role for PP2A in stabilizing 
mitotic Plk4 and promoting centriole duplication.
PP2A  is  a  holoenzyme  composed  of  three  subunits:  a 
catalytic C subunit (microtubule star [Mts] in Drosophila), a 
structural A subunit (Drosophila PP2A-29B), and a regula-
tory B subunit encoded by one of four fly genes (Tws/PR55,   
Widerborst, Well rounded, or PR72; Mayer-Jaekel et al., 1992; 
Uemura et al., 1993; Snaith et al., 1996; Hannus et al., 2002; 
Li et al., 2002; Viquez et al., 2006). To test whether PP2A is 
involved in centriole duplication, we used RNAi to deplete each 
Figure 1.  Drosophila Plk4 autophosphorylation promotes its own degradation. (A) Linear map of Drosophila Plk4 amino-terminus encoding the KD and 
the DRE. The red bar indicates the position of the conserved SBD (DSGXXT). (B) Lineup of the 50 amino acid DRE encoded by Plk4 family members. Serine 
and threonine residues are shown in red. Yellow box highlights the SBD. (C) Purified recombinant Plk4 kinase domain + DRE (wt-Plk4) but not kinase-dead 
(D156N point mutation of wt) Plk4 autophosphorylates in vitro. Coomassie-stained gel (top) and corresponding autoradiograph (bottom) are shown. 
(lanes 1 and 2) Plk4 phosphorylates itself and purified bovine myelin basic protein (MBP). (lane 3) Kinase-dead Plk4 lacks kinase activity. (lane 4) wt-Plk4 
phosphorylates kinase-dead Plk4 in trans. (D) wt-Plk4 phosphorylates purified DRE fused to maltose-binding protein (MBP-DRE) in trans but does not phos-
phorylate purified maltose-binding protein. (E) A kinase-dead mutation in Plk4 inhibits its degradation in S2 cells. Anti-GFP immunoblot of S2 cell lysates 
shows that full-length kinase-dead Plk4-GFP is more stable than wt-Plk4-GFP, which is degraded and nearly undetectable. Inducible Plk4 constructs were 
cotransfected into S2 cells with Nlp-GFP (used as a loading control and driven by its endogenous promoter). Black/white lines indicate that intervening 
lanes have been spliced out.JCB • VOLUME 195 • NUMBER 2 • 2011   234
Figure 2.  PP2A
Tws is required for centriole duplication. (A) 5-d RNAi-treated or 24-h OA-treated S2 cells were immunostained for PLP to mark centrioles and 
Hoechst stained to label DNA. Cell borders are traced with dashed lines. Bar, 5 µm. (B) PP2A inhibition by Mts, 29B, or Tws RNAi leads to centriole loss. 
After RNAi treatment, the number of PLP-immunostained centrioles per cell was measured. Graph shows the percentage of cells with the indicated number of 235 PP2A stabilizes Plk4 to induce centriole amplification • Brownlee et al.
loss of centrioles after Tws depletion (Fig. 3 C). We found this 
to be the case, as Plk4-SBM expression restored centriole num-
bers to control levels (Fig. 3 C). Together, these results suggest 
that PP2A
Tws promotes centriole duplication by stabilizing Plk4 
and, furthermore, may work by dephosphorylating key residues 
in the Plk4 SBD to block Slimb binding.
To determine directly whether PP2A is required to stabi-
lize Plk4, we overexpressed Plk4-GFP in S2 cells treated with 
OA. As described previously (Rogers et al., 2009), Plk4-GFP 
levels rise in mitotic cells (Fig. 3 D, first and second lane). 
However, PP2A inhibition dramatically prevented this increase 
in mitotic Plk4-GFP and, strikingly, eliminated Plk4-GFP in 
these cells (Fig. 3 D, third and fourth lane). To test whether this 
effect was simply caused by an inhibition of translation upon 
OA treatment, we induced the expression of GFP alone and 
then treated cells with OA. OA had no effect on GFP levels 
(unpublished data), suggesting that PP2A activity is specifically 
required for Plk4 stabilization.
PP2A dephosphorylates Plk4
Plk4 from OA-treated cells also has a distinct electrophoretic 
shift compared with control-treated cells (Fig. 3 E), suggest-
ing that Plk4 is more phosphorylated after PP2A inhibition. It 
was necessary to use the stable Plk4-SBM-GFP transgene for 
this experiment: although the SBM prevents phosphorylation 
within the SBD, multiple serines that flank this site are likely 
phosphorylated (Holland et al., 2010) and may be recognized 
by PP2A. Thus, Plk4 is likely a bona fide PP2A substrate and 
can be phosphorylated on multiple residues outside the SBD. 
Lastly, we examined whether PP2A can dephosphorylate Plk4 
in vitro using purified components. When human PP2A-A   
and -C subunits (sharing 75 and 94% identity with their fly homo-
logues) were incubated with autophosphorylated fly Plk4-KD   
(containing the DRE), PP2A dephosphorylated Plk4-KD in a 
dose-dependent manner and was inhibited by addition of OA 
(Fig. 3 F). Collectively, these results indicate that Plk4 is a 
PP2A substrate, and this interaction has a profound effect on 
Plk4 stability.
Tws overexpression is sufficient to stabilize 
Plk4 and induce centriole amplification
Because Tws protein levels peak during mitosis when Plk4 
levels are highest (Fig. 2 D), we tested whether overexpression 
of this regulatory subunit alone is sufficient to stabilize Plk4 
during periods when Plk4 is normally degraded. Tws-GFP (or 
GFP) and Plk4-GFP were coexpressed in S2 cells, and their   
levels were monitored with GFP immunoblots. Although control 
GFP overexpression had no effect on Plk4-GFP levels, Tws-
GFP overexpression dramatically increased Plk4-GFP levels in 
asynchronous cells in a dose-dependent manner (Fig. 4, A and B). 
(control RNAi = 2.0%; Tws RNAi = 2.7%) but dramatically 
elevated the frequency of mitotic spindles lacking centrosomes 
(similar experiments with prolonged Mts or PP2A-29B RNAi 
led to significant cell death; Fig. S3 C). Consistent with a role 
in centriole duplication, Mts and PP2A-29B localize to mitotic 
centrioles in S2R+ cells (Dobbelaere et al., 2008). Likewise, we 
found a fraction of Mts copurified with centrioles isolated from 
mitotic S2 cells using sucrose gradient centrifugation (Fig. 2 C). 
Together, these results suggest that a PP2A
Tws complex is re-
quired for centriole duplication and is appropriately positioned 
on mitotic centrioles.
Tws protein levels peak during mitosis
Because Plk4 protein levels peak during mitosis (Rogers et al., 
2009), we examined protein levels of PP2A subunits to deter-
mine whether they display similar cell cycle–dependent changes. 
S2 cells were chemically arrested during each cell cycle stage, 
and lysates were immunoblotted for PP2A catalytic (Mts) and 
regulatory (Tws) subunits. Although Mts protein levels were 
abundant and uniform throughout the cell cycle, Tws levels 
fluctuated and were strikingly similar to Plk4 (Rogers et al., 
2009): low during interphase but high during mitosis (Fig. 2 D). 
These findings suggest the possibility that increasing Tws levels 
during mitosis activates a PP2A
Tws complex responsible for 
stabilizing Plk4.
PP2A
Tws is required to stabilize Plk4
We next tested whether Tws is involved in the pathway regulat-
ing Plk4 stability. Depletion of Slimb increases both Plk4 levels 
and the percentage of cells with greater than two centrioles 
(Cunha-Ferreira et al., 2009; Rogers et al., 2009). Therefore, if 
loss of centrioles after PP2A
Tws depletion is caused by Plk4 deg-
radation, this effect should be rescued by codepletion of Slimb 
because Slimb mediates Plk4 degradation. Indeed, we found 
that whereas Tws RNAi reduced centriole number, Slimb/Tws 
co-RNAi (which effectively depletes both proteins; Fig. 3 A) 
completely reversed the effect and significantly decreased the 
percentage of cells containing less than two centrioles while in-
creasing cells with greater than two centrioles (Fig. 3 B). There-
fore, instead of being required for downstream steps in centriole 
assembly, PP2A
Tws likely acts upstream of Plk4 and Slimb.
We tested for a genetic interaction between PP2A
Tws and 
Plk4 by depleting PP2A
Tws in S2 cells expressing a Plk4 construct 
harboring a Slimb-binding mutation (SBM; a nonphosphorylat-
able alanine [S293A/T297A] mutation), which prevents Slimb 
binding (Cunha-Ferreira et al., 2009; Rogers et al., 2009). Like 
Slimb RNAi, Plk4-SBM expression increased the percentage of 
cells containing greater than two centrioles (Fig. 3 C; Rogers   
et al., 2009). We hypothesized that if PP2A
Tws dephosphorylates 
and stabilizes Plk4, expression of Plk4-SBM would rescue the 
centrioles per cell. Each number in a bar is the percent mean for two experiments (n = 500 cells/treatment). Asterisks mark significant differences (relative   
to control) for comparisons mentioned in the text (P < 0.02). Error bars indicate SD. (C) Mts cosediments with centrioles purified from mitotic S2 cells on   
a 20–70% sucrose gradient. Fractions (numbered) were immunoblotted for the indicated proteins. Asterisks mark the major centriole-containing fractions. 
(D) Tws protein is maximal during mitosis. (left) Graph of normalized endogenous Mts and Tws levels in asynchronous cells (Asynch) or after a 24-h drug- 
induced cell cycle arrest. Plotted values were determined from the anti-Mts and Tws immunoblots (right) shown. The graph and blots are representative 
examples of three independent experiments, all with similar results. -Tubulin ( Tub) was used as a loading control. Wdb, Widerborst; Wrd, Well rounded.
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Figure 3.  PP2A
Tws stabilizes Plk4 to promote centriole duplication. (A) Immunoblots of 6-d RNAi-treated S2 cells demonstrating knockdown of target 
proteins.  Tub, -tubulin; Cntrl, control. (B) Loss of centrioles by Tws RNAi is rescued by codepletion of Slimb. Each mean percentage of cells (numbers) 
is derived from two experiments (n = 598 cells/treatment). Asterisk indicates significant difference (P < 0.02) between compared treatments mentioned in 
the text. (C) Low expression of nondegradable Plk4-SBM-GFP also rescues the centriole loss by Tws-RNAi. Each mean percentage (numbers) is derived from 
three experiments (n = 900 cells/treatment). *, P < 0.04. (D) PP2A is required to stabilize Plk4. S2 cells overexpressing Plk4-GFP were treated with colchi-
cine or OA for 24 h as indicated, and lysates were probed for GFP. (E) PP2A dephosphorylates Plk4-SBM-GFP in cells. S2 cells expressing Plk4-SBM-GFP 
were treated with OA for 24 h, and their lysates were immunoblotted for GFP. Note the clear shift in mobility of Plk4-SBM after OA treatment (arrowheads), 
consistent with Plk4-SBM being hyperphosphorylated after PP2A inhibition. (F) PP2A dephosphorylates Plk4 in vitro. Human PP2A dephosphorylates auto-
phosphorylated Plk4-KD + DRE-(His)6 protein (Plk4-KD) but is inhibited by OA. (top) Autoradiogram; (bottom) Plk4 immunoblot. Black lines indicate that 
intervening lanes have been spliced out. Error bars indicate SD.237 PP2A stabilizes Plk4 to induce centriole amplification • Brownlee et al.
Figure 4.  Ectopic Tws expression is sufficient to stabilize Plk4 and promote centriole amplification. (A) Immunoblots of S2 cell lysates showing that Tws-
GFP overexpression stabilizes Plk4-GFP without affecting Slimb levels. S2 cells were cotransfected with inducible Plk4-GFP and inducible GFP (first lane) 
or Tws-GFP (second lane) expression constructs. After a 24-h recovery period, gene expression was induced with 1 mM CuSO4 for 20 h. Cell lysates 
were then prepared and immunoblotted for GFP, endogenous Slimb, and -tubulin ( Tub; loading control). (B) The extent of Plk4-GFP stabilization is dose 
dependent on Tws-GFP. S2 cells were cotransfected with Plk4-GFP (driven by the weak, constitutive Drosophila SAS-6 promoter) and either GFP (negative 
control) or Tws-GFP, each controlled by the copper-inducible metallothionein promoter. Cells were incubated with 0, 0.5, 1, or 2 mM CuSO4 for 24 h, 
and cell lysates were probed by GFP immunoblotting. (C) Immunoblot of S2 cell lysates showing that Plk4-GFP is also stabilized by human Tws (HsTws; 
PR55-) overexpression. (D) Tws-mCherry expression drives abnormal accumulation of Plk4-GFP on centrioles (anti-D-PLP) in interphase S2 cells. Insets show 
centrioles (dashed boxes) at higher magnification. Bars, 5 µm. (E) Tws-GFP overexpression promotes centriole amplification. Graph shows the percentage 
of transgene-expressing cells containing the indicated number of centrioles; means (numbers) derived from three experiments (n = 600 cells/treatment).   
*, P < 0.003 (treated conditions compared with GFP control). (F) Tws-GFP overexpression increases the frequency of multipolar spindles. S2 cells express-
ing GFP or Tws-GFP were immunostained for centrioles (anti-PLP, red) and -tubulin (green). DNA (blue) is Hoechst stained. Bar, 2.5 µm. Graph shows mean 
percentages (numbers) of mitotic cells with multipolar spindles (two experiments; n = 76 cells/treatment). *, P < 0.01. Error bars indicate SD.JCB • VOLUME 195 • NUMBER 2 • 2011   238
S2 cells increased the percentage of cells containing greater 
than two centrioles (Fig. 5, A and B). Notably, the effect is PP2A 
dependent because OA treatment of ST-GFP–expressing cells 
blocks centriole amplification (Fig. 5 B). Therefore, the cen-
triole amplification that follows ST expression requires PP2A 
activity and suggests that ST does not inhibit all PP2A func-
tions. This result is surprising given ST’s reported inhibitory 
effects on PP2A activity.
SV40 ST functionally mimics Tws in 
stabilizing Plk4
To determine whether abnormal Plk4 hyperstabilization is the 
causal link between PP2A activation and ST-mediated centriole 
amplification, ST-GFP and Plk4-GFP were coexpressed in S2 
cells, and their levels monitored with GFP immunoblots. Strik-
ingly, we found that ST-GFP expression increased Plk4-GFP   
levels in asynchronous cells to an extent similar to Plk4-SBM 
expression (Fig. 5 C). The effect was not caused by mitotic   
arrest (mitotic index: GFP control, 2.7%; ST-GFP, 3.2%) or a 
decrease in Slimb levels, which remained unchanged (Fig. 5 C). 
Like Tws overexpression, the ST effect was dose dependent 
(Fig. 5 D) and also induced Plk4 localization to centrioles in   
interphase cells (Fig. 5 E). Lastly, we tested whether ST expres-
sion could functionally replace Tws in centriole duplication by 
overexpressing ST in S2 cells depleted of Tws. Although Tws 
RNAi treatment of control cells expressing GFP led to centriole 
loss, ST-GFP expression in similarly treated cells rescued the 
phenotype and decreased the percentage of cells containing less 
than two centrioles (Fig. 5 B). ST expression did not rescue 
centriole loss caused by Plk4 depletion (Fig. 5 B). Therefore, 
our results suggest that ST does not inhibit all PP2A functions 
but can mimic the ability of Tws to activate PP2A, thus stabiliz-
ing Plk4 at inappropriate cell cycle stages and promoting centri-
ole amplification.
Discussion
Recent  studies  have  increased  our  understanding  of  Plk4 
inactivation considerably. Plk4 protein is maintained at near-
undetectable levels for the majority of the cell cycle by ubiquitin- 
mediated proteolysis (Fig. 6 A; Fode et al., 1996; Rogers   
et al., 2009). The ubiquitin ligase SCF
Slimb is responsible for 
Plk4 degradation and recognizes an extensively phosphorylated 
degron situated immediately downstream of the KD. Slimb is 
appropriately positioned on centrioles throughout the cell cycle 
to promote rapid Plk4 destruction, but centrioles are not re-
quired for its activity (Rogers et al., 2009). In any case, Plk4 
degradation is critical in blocking all pathways of centriole 
amplification. Unlike other Polo kinase members, Plk4 is a 
homodimer capable of autophosphorylating its DRE in trans   
to promote Slimb binding (Leung et al., 2002; Guderian et al., 
2010). Our findings demonstrate that autoregulation is a con-
served feature of Plk4. Moreover, our RNAi screen of the fly   
kinome suggests that no other kinase is required for Plk4 deg-
radation. The continuous and efficient degradation of Plk4 indi-
cates that Plk4 is immediately active when expressed and that 
control of Plk4’s protein level is key to regulating its activity.
The effect was not caused by mitotic arrest (mitotic index: 
GFP, 2.7%; Tws-GFP, 3.2%) nor caused by a decrease in Slimb 
levels, which remained unchanged (Fig. 4 A). A similar result 
was observed in S2 cells overexpressing human Tws (which 
shares 79% amino acid identity with fly Tws), in which Plk4-
GFP levels increased by fourfold (Fig. 4 C), suggesting PP2A
Tws 
may function analogously in human cells to stabilize Plk4.
If  PP2A
Tws  stabilizes  Plk4,  several  predictions  follow. 
First, Tws overexpression should drive abnormal accumulation 
of Plk4 on interphase centrosomes. Plk4-GFP localization was 
examined in interphase S2 cells overexpressing Tws-mCherry 
and  was  observed  to  be  associated  with  centrioles,  whereas 
this was not observed in cells expressing mCherry (Fig. 4 D). 
Second, Tws overexpression should drive centriole amplifica-
tion.  When  centriole  numbers  were  measured  in  Tws-GFP– 
overexpressing interphase cells, we found a significant increase 
in the percentage containing greater than two centrioles as   
compared with controls, similar to the expression of Plk4-SBM   
(Fig. 4 E). Notably, overexpression of the catalytic subunit Mts 
did not increase centriole number and was not synergistic with 
Tws coexpression (Fig. 4 E), suggesting that endogenous Mts is   
not limiting for PP2A
Tws activity. Furthermore, Tws overexpres-
sion increased the frequency of multipolar spindles in dividing 
cells by fourfold (Fig. 4 F). Therefore, Tws overexpression is 
sufficient to stabilize Plk4 during cell cycle stages when Plk4 
levels are normally low and, thus, induces centriole amplifica-
tion and multipolar spindle formation.
SV40 ST expression induces centriole 
amplification in a PP2A-dependent manner
Based on these findings, we propose that centriole duplication 
is regulated by a dynamic mechanism governing Plk4 stability:   
Plk4  autophosphorylation  of  its  DRE  promotes  SCF
Slimb- 
mediated degradation during interphase to block centriole ampli-
fication, but the phosphorylated state is reversed by mitotic 
PP2A
Tws to stabilize Plk4 and enable centriole duplication. As 
a proof of principle study, we examined whether perturbation 
of this mechanism could account for centrosome amplifica-
tion observed during oncogenic transformation by using the 
ST of the tumor-promoting virus SV40 (Kotadia et al., 2008). 
ST can act as a potent PP2A inhibitor (Arroyo and Hahn, 
2005). By directly binding to the PP2A structural A subunit, ST 
competes with and displaces endogenous regulatory subunits, 
thereby preventing the dephosphorylation of PP2A substrates 
(Chen et al., 2007b; Cho et al., 2007). Not surprisingly, given 
their high degree of conservation, ST also binds the Drosoph-
ila structural subunit PP2A-29B (Kotadia et al., 2008). How-
ever, regarding ST’s effect on centriole duplication, the notion 
that ST inhibits PP2A is paradoxical because ST expression 
promotes  centrosome  amplification  in  human  U2OS  cells, 
cultured fly Kc cells, and fly embryos (Kotadia et al., 2008), 
whereas PP2A depletion actually eliminates centrosomes in 
fly cells (Chen et al., 2007a). To resolve this issue, we tested 
the hypothesis that ST does not inhibit all PP2A functions 
but can instead act as a surrogate regulatory subunit to mimic 
the activity of Tws by stabilizing Plk4 and, thus, drive centri-
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Dobbelaere et al., 2008). A previous study found that the num-
ber of -tubulin foci in mitotic S2 cells was diminished after 
PP2A RNAi (Chen et al., 2007a), but whether this resulted from 
a bona fide loss of centrioles or instead reflects a requirement 
for PP2A for centrosome maturation was not determined. Sub-
sequently, a role for PP2A in centrosome maturation was iden-
tified in a genome-wide RNAi screen (Dobbelaere et al., 2008). 
Our results indicate that PP2A and the regulatory subunit Tws 
are required for centriole duplication by dephosphorylating and 
stabilizing Plk4. Without PP2A
Tws, Plk4 cannot be stabilized, 
However, surprisingly little is known about the converse 
event: how Plk4 is activated. Our results reveal the existence of 
a previously unknown facet of the regulation of centriole dupli-
cation, a process which transiently stabilizes and activates Plk4 
specifically during mitosis. Our study led us to investigate serine/ 
threonine phosphatases as possible effectors to counteract Plk4 
autophosphorylation. PP2A is an excellent candidate to fulfill 
this role as it has important functions in mitosis and localizes   
to mitotic centrioles in cultured fly cells and centrosomes in divid-
ing  Caenorhabditis  elegans  embryos  (Schlaitz  et  al.,  2007; 
Figure 5.  Tumor-promoting SV40 ST mimics Tws function to stabilize Plk4 and amplify centrioles. (A) S2 cells overexpressing GFP or ST-GFP (green)   
immunostained for PLP (red) to mark centrioles. DNA (blue) is Hoechst stained. (B) ST-GFP overexpression increases centriole numbers but not in the presence of 
OA. ST-GFP expression also rescues centriole loss caused by depletion of Tws but not Plk4. Centrioles were counted after 6-d RNAi or 24-h OA treatment 
in cells transfected with inducible GFP or ST-GFP (expression was induced during the last 2 d). Mean values (numbers) of two experiments are shown   
(n = 600 cells/treatment). Asterisks indicate significant differences (P < 0.05) between compared treatments mentioned in the text. Error bars indicate SD. Ctnrl, 
control. (C and D) Immunoblots show that ST-GFP overexpression stabilizes Plk4-GFP in S2 cells to levels similar to Plk4-SBM-GFP, without affecting endog-
enous Slimb levels (C) and in a dose-dependent manner (D; treatment protocol similar to that described in Fig. 4 B).  Tub, -tubulin. (E) ST-V5 expression 
drives accumulation of Plk4-GFP on centrioles (anti-PLP) in interphase S2 cells. Insets show centrioles (dashed boxes) at higher magnification. Bars, 5 µm.JCB • VOLUME 195 • NUMBER 2 • 2011   240
subunits to be displaced and inhibiting PP2A activity (Arroyo 
and Hahn, 2005; Chen et al., 2007b; Cho et al., 2007). How-
ever, our results demonstrate that ST expression does not inhibit 
all PP2A activities but, instead, stimulates PP2A stabilization 
of Plk4 (Fig. 6 C). To our knowledge, this represents the first 
evidence that ST mimics the function of a PP2A regulatory 
subunit in cells. It will be important to determine whether ST 
targets additional PP2A substrates during tumorigenesis and 
whether other tumorigenic viruses (e.g., human papillomavirus 
and hepatitis B) known to promote centrosome amplification 
(Duensing et al., 2000; De Luca et al., 2003; Yun et al., 2004; 
Nitta et al., 2006) exploit this same mechanism. Intriguingly,   
human papillomavirus E7 oncoprotein binds PP2A catalytic 
and structural subunits and prevents PP2A from dephosphory-
lating Akt (Pim et al., 2005). Although a previous study has 
suggested that PP2A may function as a tumor suppressor 
(Janssens et al., 2005), our findings indicate that unregulated 
PP2A  activity  leads  to  centriole  amplification  and  chromo-
somal instability and should therefore be considered as a poten-
tial oncogenic factor.
Materials and methods
Cell culture and double-stranded RNAi (dsRNA)
Drosophila S2 cell culture, in vitro dsRNA synthesis, and RNAi treatments 
were performed as previously described (Rogers and Rogers, 2008). In 
brief, cells were cultured in Sf900II SFM media (Life Technologies). RNAi 
was performed in 6-well plates. Cells (50–90% confluency) were treated 
with 10 µg dsRNA in 1 ml media and replenished with fresh media/dsRNA 
every other day for 4–7 d. The gene-specific primer sequences used to am-
plify DNA templates for RNA synthesis are shown in Table S1. Control dsRNA 
was synthesized from control DNA template amplified from a non-GFP   
sequence of the pEGFP-N1 vector (Takara Bio Inc.) using the primers   
5-CGCTTTTCTGGATTCATCGAC-3 and 5-TGAGTAACCTGAGGCTATGG-3 
(all primers used for dsRNA synthesis in this study begin with the T7 pro-
motes sequence 5-TAATACGACTCACTATAGGG-3). For the Drosophila 
kinome screen, 185 dsRNA were purchased from the Harvard Fly RNAi 
Center (those with amplicon numbers in Table S2). Cell cycle arrest was 
induced by treating cells for ≥24 h with a final concentration of either 
and centrioles fail to duplicate. PP2A is also required for centri-
ole assembly in C. elegans embryos but functions downstream 
in the centriole assembly process (Kitagawa et al., 2011; Song 
et al., 2011). Although the catalytic and structural PP2A sub-
units are abundant, regulatory subunits are needed for intra-
cellular targeting and recognition of a myriad of substrates. Tws 
overexpression is sufficient to stabilize Plk4 in a dose-dependent 
manner, causing centriole amplification and multipolar spindle 
formation. Like Plk4, Tws protein levels are low during inter-
phase but rise and peak during mitosis. Accordingly, our results 
suggest that PP2A
Tws stabilizes mitotic Plk4 by counteracting 
Plk4 autophosphorylation, enabling cells to switch Plk4 activity 
(and thus centriole duplication) on and off (Fig. 6 B). This mecha-
nism is inherently highly sensitive to the presence of Tws, a 
rate-limiting component. Moreover, this is likely a conserved 
mechanism because overexpression of human Tws also stabi-
lizes fly Plk4 in S2 cells. Clearly, an important goal for future 
studies is to establish whether the regulation of Tws levels and 
cell cycle control are linked. In addition, our results suggest that 
up-regulation of Tws could be a means to amplify centrioles in 
multiciliated cells and that increased Tws activity could be a 
condition found in cancerous cells.
Centrosome amplification is a hallmark of cancer and is 
also observed upon expression of DNA tumor virus proteins, 
which  include  SV40  ST,  human  papillomavirus  E7,  human   
T cell leukemia virus type-1 Tax, hepatitis B virus oncoprotein X, 
and human adenovirus E1A (Duensing et al., 2000; De Luca 
et al., 2003; Yun et al., 2004; Nitta et al., 2006; Kotadia et al., 
2008). However, mechanisms for centrosome amplification   
by viral oncoproteins are not known. SV40 ST has been found 
to directly bind the highly conserved Drosophila catalytic 
and structural PP2A subunits and to induce centrosome over-
duplication in cultured fly cells (Kotadia et al., 2008). Notably,   
ST is a well-established PP2A inhibitor and is known to bind 
structural PP2A subunits, forcing endogenous PP2A regulatory 
Figure 6.  Model depicting the regulation of Plk4 activity by a counteracting autophosphorylation/dephosphorylation mechanism. (A) Plk4 is expressed 
throughout interphase, but continuous Plk4 autophosphorylation of its DRE triggers its own proteasome-mediated degradation by inducing SCF
Slimb binding 
and ubiquitination. As a result, centriole amplification is blocked. Plk4 stabilization can be achieved by PP2A activity, which dephosphorylates Plk4. How-
ever, this does not normally occur because its required regulatory subunit, Tws, is present at insufficient levels. (B) During mitosis, Tws protein levels rise, thus 
activating a PP2A
Tws complex, which counteracts Plk4 autophosphorylation. Plk4 is stabilized and modifies centrioles, making them competent to duplicate 
during the next S phase. Upon mitotic exit, Tws levels decrease, and PP2A is unable to maintain Plk4 stability. (C) This same mechanism is exploited by 
tumor-promoting SV40 ST. ST binds PP2A and functionally mimics Tws, counteracting Plk4 autophosphorylation. Plk4 is inappropriately stabilized during 
interphase, localizes to centrioles, and thus, promotes centriole amplification. CPB, cryptic polo box; PB, polo box.241 PP2A stabilizes Plk4 to induce centriole amplification • Brownlee et al.
In vitro kinase and phosphatase assays
For in vitro kinase assays, Drosophila (His)6-tagged Plk4 KD + DRE (amino 
acids 1–317) was cloned into the pET28a vector, expressed in BL21(DE3) 
E. coli, and purified on TALON resin (Takara Bio Inc.) according to the 
manufacturer’s instructions. Kinase assays were conducted in reaction buf-
fer (40 mM Na Hepes, pH 7.3, 150 mM NaCl, 5 mM MgCl2, 0.5 mM 
MnCl2, 0.1 mM dithiothreitol, and 0.1 mM PMSF) and containing 10% 
(final concentration by volume) glycerol and 85 µM -[
32P]ATP at 25°C 
for 1–2 h. Some assays included 6 µg of the generic phosphorylation 
substrate and purified and dephosphorylated bovine brain myelin basic 
protein (Millipore). Reactions were terminated by the addition of Laemmli 
sample buffer and boiling. Reaction samples were resolved on SDS-PAGE, 
Coomassie stained, and then exposed to x-ray film (or a phosphorimaging 
screen [Molecular Dynamics]) to detect radiolabeled bands.
For in vitro phosphatase assays, purified Drosophila (His)6-tagged 
Plk4 KD + DRE with or without the corresponding kinase-dead Plk4 mutant   
(a  D156N  point  mutation;  also  bacterially  expressed  and  purified  on 
TALON resin) were first incubated with -[
32P]ATP to generate phosphory-
lated Plk4 (kinase-dead Plk4 was included in this assay because it incor-
porated more 
32P radiolabel than active Plk4). Specifically, 4.3 µM (final 
concentration) wt-Plk4, 4.7 µM kinase-dead Plk4, and 85 µM -[
32P]ATP 
were incubated in the conditions described in the previous paragraph. 
After 2 h at 25°C, Plk4 was bound to fresh TALON resin, and the resin was 
washed with reaction buffer to remove ATP. To assay the dephosphoryla-
tion of Plk4 by purified human PP2A (Millipore), resin-bound phosphory-
lated Plk4 was incubated with various concentrations of PP2A and OA   
(1 µM final concentration when present) in reaction buffer at 37°C for   
1.5 h. Samples were resolved on SDS-PAGE, Coomassie stained, and then 
exposed to x-ray film to detect radiolabeled bands.
Flow cytometry
S2 cells (10
6) were pelleted at 1,000 g for 5 min, resuspended in 0.5 ml 
PBS, and vortexed while intermittently adding 0.5 ml of cold 100% etha-
nol. Fixed cells were incubated on ice for 20 min, pelleted (1,000 g for   
5 min), and resuspended in a 0.5 ml propidium iodide (PI)-RNase solu-
tion (50 µg/ml PI + 100 µg/ml RNase Type1 I-A [QIAGEN] in PBS). After 
20 min, cells were passed through a 12 × 75–mm flow cytometry tube 
(Falcon; Thermo Fisher Scientific). Cytometric analysis was performed in 
the Arizona Cancer Center/Arizona Research Laboratories Division of 
Biotechnology Cytometry Core Facility using a FACScan flow cytometer   
(BD) equipped with an air-cooled 15-mW argon ion laser tuned to 488 nm. 
List mode data files consisting of 10,000 cells gated on forward scatter   
versus  side  scatter  were  acquired  and  analyzed  using  CellQuest  Pro 
software  (BD).  Appropriate  electronic  compensation  was  performed   
by acquiring cell populations stained with PI individually as well as an 
unstained control.
Centriole purification
Mitotic centrioles were purified as previously described by Mitchison and 
Kirschner (1986). In brief, a 400-ml S2 cell suspension culture was treated 
with 25 µM colchicine for 24 h, pelleted, and washed with the following 
buffers in succession: (a) PBS, (b) 0.1× PBS + 8% sucrose, (c) 8% sucrose, 
(d) lysate buffer (1 mM Tris-HCl, pH 8.0, and 8 mM 2-mercaptoethanol), 
and (e) lysate buffer + IGEPAL CA-630. The cell lysate was centrifuged for 
3 min at 1,500 g at 4°C, and the supernatant was spun through a 2 ml Ficoll 
cushion (20% [wt/wt] Ficoll 400, 0.1% [wt/vol] IGEPAL CA-630, 1 mM 
EDTA, and 8 mM 2-mercaptoethanol, pH 8.0) at 26,000 g for 15 min at 
4°C. 2 ml of the supernatant above the Ficoll cushion was removed, loaded 
onto a 30-ml 20–70% sucrose cushion (prepared in 0.1% Triton X-100, 1 mM 
EDTA, and 8 mM 2-mercaptoethanol, pH 8.0), and centrifuged for 1.5 h at 
27,000 rpm in a SW28 rotor (Beckman Coulter) at 4°C. Gradients were frac-
tionated into 0.5-ml fractions and boiled in Laemmli sample buffer for 5 min.
Online supplemental material
Fig. S1 is an illustration that shows our current understanding of the cell 
cycle–dependent regulation of Plk4. Fig. S2 shows that Plk4 protein levels 
in S2 cells are unaffected in an RNAi screen of the Drosophila kinome. 
Fig. S3 shows that Tws RNAi eliminates mitotic centrosomes in S2 cells but 
does not affect cell cycle progression. Table S1 lists the primer sequences 
that were used to generate dsRNA in this study. Table S2 shows a list of 
Drosophila kinases depleted in an RNAi screen and their effects on Plk4 
protein levels. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201107086/DC1.
We thank T. Uemura for reagents and S. Rogers, P. Krieg, and S. Ghosh for 
helpful comments on the manuscript.
0.5 mM mimosine (for a G1-phase arrest), 1 µM hydroxyurea + 10 µM   
aphidicolin (S-phase arrest), 1.7 µM 20-hydroxyecdysone (G2-phase arrest), 
or 12 h of 30 µM colchicine (M-phase arrest; this treatment produces   
a mitotic index of 30%) as previously described (Rogers et al., 2009).   
OA was used at final concentrations ranging from 1 to 100 nM.
Immunofluorescence microscopy
For immunostaining, S2 cells were fixed and processed exactly as pre-
viously described (Rogers and Rogers, 2008) by spreading S2 cells on 
concanavalin A–coated, glass-bottom dishes and fixing with 10% formal-
dehyde. Primary antibodies were diluted to concentrations ranging from 
1 to 20 µg/ml. They included rabbit and guinea pig anti–pericentrin-like 
protein (PLP; produced in laboratory), anti-GFP antibodies (monoclonal JL8 
and polyclonal Living Colors; Takara Bio Inc.), rabbit anti-Plk4 KD (pro-
duced in laboratory), anti-V5 (Life Technologies), anti–-tubulin DM1a and 
-tubulin GTU88 (Sigma-Aldrich), mouse and rabbit antiphospho–histone 
H3 (Millipore; Cell Signaling Technology), anti-FLAG M2 (Sigma-Aldrich), 
and FITC-conjugated anti–-tubulin DM1a (Sigma-Aldrich). Secondary anti-
bodies (conjugated with Cy2, Rhodamine red-X, or Cy5 [Jackson Immuno-
Research  Laboratories,  Inc.])  were  used  at  manufacturer-recommended 
dilutions. Hoechst 33342 (Life Technologies) was used at a final dilution 
of 3.2 µM. Cells were mounted in 0.1 M n-propyl galate, 90% (by volume) 
glycerol, and 10% PBS solution. Specimens were imaged at room tempera-
ture using a DeltaVision Core system (Applied Precision) equipped with a 
microscope (IX71; Olympus), a 100× objective, NA 1.4, and a cooled 
charge-coupled device camera (CoolSNAP HQ
2; Photometrics). Images 
were acquired with softWoRx v1.2 software (DeltaVision). Statistical analy-
ses of centriole and mitotic spindle counts were performed using two-tailed 
two-sample t tests and assuming equal variances.
Immunoblotting
S2 cell extracts were produced by lysing cells in PBS and 0.1% Triton 
X-100. The Bradford protein assay (Bio-Rad Laboratories; per manufac-
turer’s instructions) was used to measure lysate protein concentrations. 
Laemmli sample buffer was then added, and samples were boiled for 
5 min. The efficiency of RNAi was determined by Western blotting of 
treated  cell  lysates;  equal  total  protein  was  loaded  for  each  sample, 
and the integrated densities of chemiluminescent bands (measured with 
ImageJ [National Institutes of Health]) were normalized relative to the 
integrated densities of the loading control. Either endogenous -tubulin or 
transfected Nlp-EGFP (a constitutively expressed nuclear protein; Rogers 
et al., 2009) was used as a loading control.
Antibodies
Escherichia coli–expressed GST- or maltose-binding protein–Slimb (amino 
acids 1–91) proteins were purified on either glutathione-Sepharose or amy-
lose resin (Rogers et al., 2008, 2009). Guinea pig antisera were raised 
against GST-tagged purified Slimb protein, and the corresponding maltose-
binding protein fusion was used for antibody affinity purification by pre-
coupling to Affi-Gel 10/15 resin (Bio-Rad Laboratories). Rabbit anti-Plk4 
polyclonal antibodies were raised against a peptide (KLPHERITLEAVLC) 
corresponding to the carboxy-terminus of the Plk4 KD. Antibodies were 
affinity purified from antisera using resin with coupled peptide. Additional   
antibodies used for Western blotting include polyclonal anti-Tws and anti-Mts 
(gift from T. Uemura, Kyoto University, Kyoto, Japan; Shiomi et al., 1994), 
monoclonal anti-Mts (Millipore), monoclonal anti-GFP JL8, and polyclonal 
anti-GFP  Living  Colors,  and  anti-FLAG  used  at  1:1,000  dilutions.  HRP-
conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, 
Inc.) were prepared according to the manufacturer’s instructions and used 
at 1:1,500 dilutions.
Constructs and transfection
A genomic region of 208 residues immediately upstream of the fly SAS-6 
gene (called SAS-6p) was subcloned into the pMT vector (Life Technolo-
gies) to serve as a promoter of Plk4-GFP, constitutively promoting low level 
expression of this transgene, and was used for localization experiments 
(Rogers et al., 2009). cDNAs encoding SV40 ST (Addgene), Plk4 (Rogers 
et al., 2009), Mts/CG7109 (EST database: Drosophila LD26077, acces-
sion no. AY058571), Tws/CG6235 (EST database: Drosophila LD12394, 
accession no. AY061152), and human Tws/PPP2R2B (Open Biosystems) 
were subcloned into the inducible metallothionein promoter pMT vector 
and tagged with either FLAG, GFP, mCherry, or V5. Expression of all con-
structs was induced by addition of 0.5–2 mM copper sulfate to the media. 
Transient transfections were performed using the Nucleofector II (Lonza) 
according to manufacturer’s instructions.JCB • VOLUME 195 • NUMBER 2 • 2011   242
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